215930-27-1

Upstream product

• 179626-04-1 2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-N-[2-methyl-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-acetamide 
• 179626-02-9 2-Methyl-8-[2-methyl-3-nitrobenzyloxy]quinoline 
• 179626-03-0 2-Methyl-3-(2-methyl-quinolin-8-yloxymethyl)-phenylamine 
• 196500-09-1 2-methyl-3-nitrobenzyl methanesulfonate 
• 23876-13-3 (2-methyl-3-nitrophenyl)methanol 
• 826-81-3 2-methyl-8-quinolinol 
• 179626-05-2 2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-N-methyl-N-[2-methyl-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-acetamide 

Relevant academic research and scientific papers

A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation

In recent articles we reported the identification of a series of 8- [[2,6-dichloro-3-[N-methyl-N-[(E)- (substituted)acryloylglycyl]amino]benzyl]oxy]-2-methylimidazo[1,2- a]pyridines as the first orally active non-peptide bradykinin (BK) B2 rece